- Report
- August 2025
- 198 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2025
- 198 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2025
- 182 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2025
- 188 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- May 2024
- 200 Pages
Global
From €3727EUR$4,150USD£3,184GBP
- Report
- July 2024
- 100 Pages
Global
From €3368EUR$3,750USD£2,877GBP
- Report
- February 2024
- 75 Pages
Asia Pacific
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 110 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- February 2024
- 132 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 113 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- April 2023
- 120 Pages
Global
From €4266EUR$4,750USD£3,644GBP
- Report
- June 2025
- 400 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- October 2024
- 200 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- April 2023
- 160 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- February 2024
- 124 Pages
Global
From €3817EUR$4,250USD£3,261GBP
- Report
- March 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- August 2025
- 150 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- July 2024
- 156 Pages
Global
From €3054EUR$3,400USD£2,609GBP
€3817EUR$4,250USD£3,261GBP
- Report
- July 2024
- 154 Pages
Global
From €3054EUR$3,400USD£2,609GBP
€3817EUR$4,250USD£3,261GBP

The Blood Component market is a subset of the biopharmaceutical industry that focuses on the production and distribution of blood components, such as red blood cells, platelets, and plasma. These components are used to treat a variety of medical conditions, including anemia, cancer, and trauma. The market is highly regulated, with stringent safety and quality standards in place to ensure the safety of the products.
The Blood Component market is a highly competitive space, with a number of companies vying for market share. Some of the major players in the market include Grifols, CSL Behring, Octapharma, Kedrion, and Biotest. Show Less Read more